cached image

Terry Moore, Ph.D. - Publications

Affiliations: 
2003-2009 Chemistry University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
 2009-2013 Chemistry Emory University, Atlanta, GA 
 2013- Medicinal Chemistry and Pharmacognosy University of Illinois at Chicago, Chicago, IL, United States 
Area:
steroid hormones
Website:
moorelab.publish.uic.edu

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Zink KE, Ludvik DA, Lazzara PR, Moore TW, Mandel MJ, Sanchez LM. A Small Molecule Coordinates Symbiotic Behaviors in a Host Organ. Mbio. 12. PMID 33688014 DOI: 10.1128/mBio.03637-20  0.734
2020 Lazzara PR, Moore TW. Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds. Rsc Medicinal Chemistry. 11: 18-29. PMID 33479602 DOI: 10.1039/c9md00396g  0.75
2020 Lazzara PR, Jain AD, Maldonado AC, Richardson B, Skowron KJ, David BP, Siddiqui Z, Ratia KM, Moore TW. Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors. Acs Medicinal Chemistry Letters. 11: 521-527. PMID 32292559 DOI: 10.1021/Acsmedchemlett.9B00631  0.742
2020 Lazzara PR, Moore TW. Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds Rsc Medicinal Chemistry. 11: 18-29. DOI: 10.1039/c9md00396g  0.744
2019 Lazzara PR, David BP, Ankireddy A, Richardson B, Dye K, Ratia KM, Reddy SP, Moore TW. Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability. Journal of Medicinal Chemistry. PMID 31682434 DOI: 10.1021/Acs.Jmedchem.9B01074  0.752
2019 Skowron KJ, Booker K, Cheng C, Creed S, David BP, Lazzara PR, Lian A, Siddiqui Z, Speltz TE, Moore TW. Steroid receptor/coactivator binding inhibitors: An update. Molecular and Cellular Endocrinology. 110471. PMID 31163202 DOI: 10.1016/J.Mce.2019.110471  0.754
2018 Skowron KJ, Speltz TE, Moore TW. Recent structural advances in constrained helical peptides. Medicinal Research Reviews. PMID 30307621 DOI: 10.1002/med.21540  0.764
2018 Richardson B, Jain AD, Potteti H, Lazzara PR, David BP, Tamatam C, Choma E, Skowron K, Dye K, Siddiqui Z, Wang YT, Krunic A, Reddy S, Moore TW. Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear factor (erythroid-derived 2)-like 2 (NRF2)Inhibitors. Journal of Medicinal Chemistry. PMID 30122040 DOI: 10.1021/Acs.Jmedchem.8B01133  0.753
2018 David BP, Dubrovskyi O, Speltz TE, Wolff JJ, Frasor J, Sanchez LM, Moore TW. Using Tumor Explants for Imaging Mass Spectrometry Visualization of Unlabeled Peptides and Small Molecules. Acs Medicinal Chemistry Letters. 9: 768-772. PMID 30034616 DOI: 10.1021/Acsmedchemlett.8B00091  0.75
2018 Speltz TE, Mayne CG, Fanning SW, Siddiqui Z, Tajkhorshid E, Greene GL, Moore TW. A "cross-stitched" peptide with improved helicity and proteolytic stability. Organic & Biomolecular Chemistry. PMID 29725689 DOI: 10.1039/C8Ob00790J  0.771
2018 Speltz TE, Danes JM, Stender JD, Frasor J, Moore TW. A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction. Acs Chemical Biology. PMID 29309722 DOI: 10.1021/Acschembio.7B01016  0.793
2016 Yao Y, Kong C, Yin L, Jain AD, Ratia K, Thatcher GR, Moore TW, Driver T, Miller LW. Time-gated detection of cystathionine γ-lyase activity and inhibition with a selective, luminogenic hydrogen sulfide sensor. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 27734530 DOI: 10.1002/Chem.201604786  0.391
2016 Speltz TE, Fanning SW, Mayne CG, Fowler C, Tajkhorshid E, Greene GL, Moore TW. Stapled Peptides with γ-Methylated Hydrocarbon Chains for the Estrogen Receptor/Coactivator Interaction. Angewandte Chemie (International Ed. in English). PMID 26928945 DOI: 10.1002/Anie.201510557  0.78
2016 Speltz TE, Fanning SW, Mayne CG, Fowler C, Tajkhorshid E, Greene GL, Moore TW. Inside Cover: Stapled Peptides with γ-Methylated Hydrocarbon Chains for the Estrogen Receptor/Coactivator Interaction (Angew. Chem. Int. Ed. 13/2016) Angewandte Chemie International Edition. 55: 4104-4104. DOI: 10.1002/Anie.201601641  0.78
2016 Speltz TE, Fanning SW, Mayne CG, Fowler C, Tajkhorshid E, Greene GL, Moore TW. Innentitelbild: Stapled Peptides with γ-Methylated Hydrocarbon Chains for the Estrogen Receptor/Coactivator Interaction (Angew. Chem. 13/2016) Angewandte Chemie. 128: 4174-4174. DOI: 10.1002/Ange.201601641  0.78
2015 Xiong R, Patel HK, Gutgesell LM, Zhao J, Delgado-Rivera L, Pham TN, Zhao H, Carlson KE, Martin TA, Katzenellenbogen JA, Moore TW, Tonetti D, Thatcher GR. Selective human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer. Journal of Medicinal Chemistry. PMID 26681208 DOI: 10.1021/Acs.Jmedchem.5B01276  0.504
2015 Jain AD, Potteti H, Richardson BG, Kingsley L, Luciano JP, Ryuzoji AF, Lee H, Krunic A, Mesecar AD, Reddy SP, Moore TW. Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators. European Journal of Medicinal Chemistry. 103: 252-268. PMID 26363505 DOI: 10.1016/J.Ejmech.2015.08.049  0.793
2015 Richardson BG, Jain AD, Speltz TE, Moore TW. Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway. Bioorganic & Medicinal Chemistry Letters. 25: 2261-8. PMID 25937010 DOI: 10.1016/J.Bmcl.2015.04.019  0.756
2015 Moore TW, Gunther JR, Katzenellenbogen JA. Estrogen receptor alpha/co-activator interaction assay: TR-FRET. Methods in Molecular Biology (Clifton, N.J.). 1278: 545-53. PMID 25859975 DOI: 10.1007/978-1-4939-2425-7_36  0.671
2015 Moore TC, Vogel AJ, Petro TM, Brown DM. IRF3 deficiency impacts granzyme B expression and maintenance of memory T cell function in response to viral infection. Microbes and Infection / Institut Pasteur. 17: 426-39. PMID 25777301 DOI: 10.1016/j.micinf.2015.03.001  0.305
2015 Zhu S, Kisiel W, Lu YJ, Petersen LC, Ndungu JM, Moore TW, Parker ET, Sun A, Sarkaria JN, Snyder JP, Liotta DC, Brat DJ, El-Rayes BF, Shoji M. Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody. Journal of Drug Targeting. 23: 257-65. PMID 25510254 DOI: 10.3109/1061186X.2014.988217  0.38
2014 Zhu S, Kisiel W, Lu YJ, Petersen LC, Ndungu JM, Moore TW, Parker ET, Sun A, Liotta DC, El-Rayes BF, Brat DJ, Snyder JP, Shoji M. Tumor angiogenesis therapy using targeted delivery of Paclitaxel to the vasculature of breast cancer metastases. Journal of Drug Delivery. 2014: 865732. PMID 25574399 DOI: 10.1155/2014/865732  0.384
2014 Grimmer C, Moore TW, Padwa A, Prussia A, Wells G, Wu S, Sun A, Snyder JP. Antiviral atropisomers: conformational energy surfaces by NMR for host-directed myxovirus blockers. Journal of Chemical Information and Modeling. 54: 2214-23. PMID 25058809 DOI: 10.1021/Ci500204J  0.72
2013 Moore TW, Sana K, Yan D, Krumm SA, Thepchatri P, Snyder JP, Marengo J, Arrendale RF, Prussia AJ, Natchus MG, Liotta DC, Plemper RK, Sun A. Synthesis and Metabolic Studies of Host Directed Inhibitors for Anti Viral Therapy. Acs Medicinal Chemistry Letters. 4: 762-767. PMID 23956816 DOI: 10.1021/Ml400166B  0.745
2013 Brown A, Shi Q, Moore TW, Yoon Y, Prussia A, Maddox C, Liotta DC, Shim H, Snyder JP. Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties. Journal of Medicinal Chemistry. 56: 3456-66. PMID 23550937 DOI: 10.1021/Jm4002692  0.755
2013 Moore TW, Sana K, Yan D, Thepchatri P, Ndungu JM, Saindane MT, Lockwood MA, Natchus MG, Liotta DC, Plemper RK, Snyder JP, Sun A. Asymmetric synthesis of host-directed inhibitors of myxoviruses. Beilstein Journal of Organic Chemistry. 9: 197-203. PMID 23400228 DOI: 10.3762/Bjoc.9.23  0.78
2012 Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, Snyder JP, Yoon Y, Shim H, Marcus AI, Miller AH, Pace TW. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. International Immunopharmacology. 12: 368-77. PMID 22197802 DOI: 10.1016/J.Intimp.2011.12.009  0.423
2011 Sun A, Moore TW, Gunther JR, Kim MS, Rhoden E, Du Y, Fu H, Snyder JP, Katzenellenbogen JA. Discovering small-molecule estrogen receptor α/coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency. Chemmedchem. 6: 654-66. PMID 21365764 DOI: 10.1002/Cmdc.201000507  0.753
2010 Moore TW, Gunther JR, Katzenellenbogen JA. Probing the topological tolerance of multimeric protein interactions: evaluation of an estrogen/synthetic ligand for FK506 binding protein conjugate. Bioconjugate Chemistry. 21: 1880-9. PMID 20919698 DOI: 10.1021/Bc100266V  0.696
2010 Moore TW, Mayne CG, Katzenellenbogen JA. Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs). Molecular Endocrinology (Baltimore, Md.). 24: 683-95. PMID 19933380 DOI: 10.1210/Me.2009-0362  0.74
2009 Gunther JR, Du Y, Rhoden E, Lewis I, Revennaugh B, Moore TW, Kim SH, Dingledine R, Fu H, Katzenellenbogen JA. A set of time-resolved fluorescence resonance energy transfer assays for the discovery of inhibitors of estrogen receptor-coactivator binding. Journal of Biomolecular Screening. 14: 181-93. PMID 19196699 DOI: 10.1177/1087057108329349  0.691
2009 Moore TW, Katzenellenbogen JA. Inhibitors of nuclear hormone receptor/coactivator interactions Annual Reports in Medicinal Chemistry. 44: 443-457. DOI: 10.1016/S0065-7743(09)04421-2  0.613
2008 Gunther JR, Moore TW, Collins ML, Katzenellenbogen JA. Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interaction. Acs Chemical Biology. 3: 282-6. PMID 18484708 DOI: 10.1021/Cb800056R  0.76
Show low-probability matches.